期刊文献+

隐孢子虫感染小鼠补骨脂治疗效果评价 被引量:4

Therapeutic effect of Fructus psoraleae and dihydroartemisinin on cryptosporidiosis in mice
原文传递
导出
摘要 目的观察补骨脂、双氢青蒿素及二者配伍治疗隐孢子虫感染小鼠前后的肠壁黏膜组织病理变化和T细胞表面的CD28分子表达水平,探讨这3组中药对隐孢子虫病防治的疗效。方法 60只昆明种小鼠随机分成正常组A、阳性对照组B、补骨脂治疗组C、双氢青蒿素治疗组D以及二者配伍治疗组E。经1和2周药物治疗后,观察各组小鼠肠壁黏膜组织病理变化和T细胞表面的CD28分子表达水平。结果经过1和2周的治疗,药物治疗组小鼠的粪便卵囊量与阳性对照组比较,均明显减少(P<0.05);小肠病理学显示,小肠上皮处于修复之中。在经药物治疗后,所有治疗组的CD28分子表达明显高于阳性对照组B1(P<0.05),补骨脂治疗组C2最高(64.01±5.39),明显高于双氢青蒿素治疗组D2(P<0.05)。结论补骨脂和双氢青蒿素能抑杀隐孢子虫,其中双氢青蒿素杀虫效果明显,而补骨脂主要通过调节外周血CD28分子,以及CD4+与CD3+T细胞比例,二者通过协同作用,参与宿主免疫应答和炎症反应过程,最终修复炎症反应。 Objective To investage the effects of Fructus Psoraleae and dihydroartemisinin on expression of CD28,pathological change of intestine in mice infected with Cryptosporidium parvum.Methods Cryptosporidium parvum infection was induced by hypodermic injection of dexamethasone in mice,twice a week for 4 weeks.Sixty mice were divided into 5 groups in random:A(normal group),B(control group),C(therapeutic group of Fructus psoraleae),D(therapeutic group of dihydroartemisinin),E(therapeutic group of the two agents combination).According to the period of therapy(1 or 2 weeks),therapeutic groups were subdivided into A1,A2,B1,B2,C1,C2,D1,D2,and E1,E2.Results Compared with the control group,the number of Crypatosporidium parvum oocysts in feces were decreased obviously in all treatment groups(P0.05).The pathological damage of intestinal epitheliums were renovated after therapeutic treatment.Proportions of CD28 T lymphocytes in peripheral blood in all treatment groups were higher than those of infected control groups(P0.05).Conclusion Fructus psoraleae and dihydroartemisinin are effective in the treatment of cryptosporidiosis in mice.Dihydroartemisinin can remarkably eliminate Cryptosporidium parvum.Fructus psoraleae can up-regulate peripheral blood CD28 and proportion of CD4+ and CD3+ T cells.The two agents participate in the host immune response and inflammatory reaction with synergic effect and ultimately restore inflammatory responce.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第6期725-726,共2页 Chinese Journal of Public Health
基金 国家科技部基金项目(2005DK21100)
关键词 补骨脂 双氢青蒿素 隐孢子虫 Fructus psoraleae dihydroartemisinin Cryptosporidium parvum
  • 相关文献

参考文献3

二级参考文献29

  • 1姚福宝,陈有贵.小儿隐孢子虫病大蒜素治疗效果简报[J].徐州医学院学报,1989,9(1):56-57. 被引量:7
  • 2Chambers CA, Allison JP. Co-stimulation in T cell responses. Curr Opin Immunol, 1997,9(3):396
  • 3Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol ,2004,4(5) : 336
  • 4Wong CK, Lun SW, Ko FW et al. Increased expressionof plasma and cell surface co-stimulatory molecules CT-LA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol, 2005 ,141(1):122
  • 5Van Neerven RJ, Van de Pol MM, Van der Zee JS et al.Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy, 1998,28(7) : 808
  • 6Burr JS, Kimzey SL, Randolph DR et al. CD28 and CT-LA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am J Respir Cell Mol Biol,2001,24(5) : 563
  • 7Vigona AM, Chiappara G, Siena L et al. Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. J Allergy Clin Immunol, 2001, 108(5) :738
  • 8Bousquet J, Van Cauwenberge P, Khaktaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol, 2001,108(Suppl): S147
  • 9Chang TT,Kuchroo VK,Sharp AH.Role of the B7-CD28/ CTLA-4 pathway in autoimmune disease.Curr Dir Autoimmun,2002,5(1):113-130.
  • 10Chikuma S,Abbas AK,Bluestone JA.B7-independent inhibition of T cells by CTLA-4.J Immunol,2005,175 (1):177-181.

共引文献21

同被引文献71

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部